Ironwood Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +32.3% | -40.4% | +24.7% | +33.4% | +8.5% | -26.6% | +17.3% | -19.0% | +99.0% | -47.4% | +48.7% | +28.3% | -3.7% | -36.7% | +11.9% | +15.7% | +12.8% | -23.9% | +17.1% | -0.3% | +12.9% | -16.7% | -0.3% | +11.7% | -1.3% | -2.9% | +3.2% | +5.9% | +3.4% | -36.3% | +26.1% | -3.0% | -1.1% | -54.6% | +107.2% | +43.2% | -60.9% | +123.2% | +6.1% | – | |
| – | -95.0% | -71.6% | +559.5% | +73.6% | +50.1% | -71.4% | +55.9% | +13.6% | +365.0% | -95.1% | +984.7% | -95.5% | +2,076.5% | -79.7% | -71.4% | +3,289.4% | -95.9% | +1,626.2% | -21.4% | -10.3% | -96.7% | +2,922.9% | -96.7% | +0.8% | -6.3% | -15.9% | +6,815.0% | -97.4% | +1.0% | +4,942.0% | -98.0% | +5,794.7% | +163.1% | -65.0% | -98.3% | +1.7% | -3.2% | -3.7% | – | – | |
| – | +199.5% | -39.7% | +19.3% | +31.1% | +5.4% | -21.8% | +15.8% | -20.7% | +78.9% | -38.0% | +34.3% | +43.7% | -11.8% | -32.6% | +14.3% | -7.9% | +41.6% | -36.6% | +25.2% | +1.1% | +25.8% | -25.7% | +11.7% | +11.8% | -1.3% | -2.9% | -15.6% | +29.3% | +3.8% | -58.3% | +92.4% | -34.6% | +46.6% | -84.9% | +518.3% | +43.4% | -60.8% | +122.3% | +6.6% | – | |
| – | +2.4% | -12.3% | +10.8% | -0.7% | +8.2% | -9.0% | +6.6% | +20.2% | -5.4% | +22.0% | -46.7% | -4.2% | -3.7% | +5.6% | -23.5% | +1.2% | -25.0% | +13.0% | -33.8% | -10.3% | +188.7% | -65.6% | +2.5% | +0.8% | -9.6% | +24.3% | +8,856.5% | -97.1% | +10.5% | -27.6% | +17.7% | -1.8% | -14.9% | +8.0% | -16.5% | -4.0% | -0.6% | -1.7% | +4.3% | – | |
| – | +22.7% | +0.7% | +3.9% | +6.9% | -6.2% | +6.9% | +10.4% | -19.2% | +5.3% | +11.3% | -33.2% | -5.4% | -4.2% | -7.0% | -5.0% | +0.8% | -2.7% | -18.6% | -2.2% | +2.6% | +3.4% | +0.6% | +4.4% | -5.0% | -0.8% | +9.6% | +68.7% | -31.3% | +7.3% | -2.7% | -1.7% | -2.3% | -7.0% | -27.8% | -30.8% | +30.4% | -11.9% | -37.6% | -6.0% | – | |
| – | +5.4% | -0.7% | +6.5% | +5.4% | +0.8% | +0.4% | +8.7% | -6.8% | -0.7% | +15.9% | -39.4% | -4.9% | -4.1% | -1.9% | -13.0% | -35.5% | +78.1% | -56.6% | -4.3% | +3.4% | +117.5% | -52.0% | +42.8% | -3.4% | -3.3% | +13.5% | +2,580.4% | -94.5% | +23.7% | -52.4% | +82.5% | -48.0% | +63.5% | -27.5% | -7.3% | +10.6% | -6.3% | -18.5% | +0.6% | – | |
| – | – | – | – | – | – | -257.6% | – | – | – | -1,007.0% | – | +205.4% | -24.7% | -73.3% | +147.3% | +39.4% | +12.6% | -11.6% | +43.4% | +0.1% | -13.2% | +2.2% | -3.8% | +23.0% | -0.2% | -12.1% | -1,902.3% | – | -22.7% | -70.7% | +126.7% | +2.6% | +22.8% | -192.4% | – | +72.4% | -91.6% | +1,006.9% | +9.3% | – | |
| – | -1.1% | -7.0% | +0.7% | +1.0% | +0.8% | +0.7% | +1.2% | +1.1% | +1.1% | +0.1% | -1.7% | +10.9% | -31.9% | +1.4% | +1.4% | +1.4% | +1.4% | +1.4% | +1.4% | +1.4% | +1.4% | -70.6% | -5.7% | -30.9% | +0.1% | +0.1% | +20.5% | +434.7% | -14.4% | -14.2% | +3.3% | +26.1% | -5.4% | -9.5% | +3.5% | +0.9% | -6.5% | +15.9% | -21.2% | – | |
| – | – | – | – | – | – | -457.0% | – | – | – | – | – | +68.1% | +131.8% | -93.0% | +653.5% | +42.1% | +24.3% | -9.3% | +34.7% | +9.7% | -22.5% | +22.1% | -4.7% | +30.0% | +3.4% | -8.9% | -1,734.1% | – | -4.9% | -83.7% | +280.7% | -8.0% | +38.1% | -251.2% | – | +79.8% | -99.3% | +14,223.5% | +13.1% | – | |
| – | -1.6% | -3.5% | +0.7% | +1.0% | -6.0% | +0.1% | +0.7% | +9.6% | -21.1% | +28.2% | -0.2% | +10.0% | -37.7% | +5.2% | +0.8% | -80.0% | -6.7% | -66.7% | -78,093.3% | – | +27.5% | +261.9% | -5.4% | +17.3% | +19.4% | -13.9% | -34.2% | +35.7% | +78.5% | -71.6% | +116.4% | -30.5% | +58.4% | -94.9% | +1,176.8% | +96.4% | -90.2% | +793.4% | -8.0% | – | |
| – | – | – | – | – | – | -457.0% | – | – | – | – | – | +68.1% | +131.8% | -93.0% | +653.5% | +36.6% | +25.5% | -7.6% | +880.1% | -85.7% | -25.9% | -6.2% | -4.4% | +35.7% | -2.9% | -6.5% | -2,423.5% | – | -107.1% | – | – | – | -38.1% | -1,757.2% | – | +69.8% | -105.7% | – | +25.8% | – | |
| – | – | – | – | – | – | -207.7% | – | – | – | – | – | +50.6% | +64.4% | -80.5% | +204.2% | +46.8% | +10.0% | -13.8% | +41.4% | +0.4% | -16.6% | +8.4% | -4.7% | +27.4% | +3.3% | -8.7% | -16.8% | -24.9% | -4.1% | -70.5% | +124.3% | +1.6% | +22.3% | -130.2% | – | +64.9% | -88.6% | +749.4% | +8.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.